Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 17 citing Ziegler: Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral.... (0.10 sec) 

Treatment of diabetic neuropathy and neuropathic pain


D Ziegler - Diabetes care, 2008 - Am Diabetes Assoc
At least one of four diabetic patients is affected by distal symmetric
polyneuropathy, which represents a major health problem, since it may present
with partly excruciating neuropathic pain and is responsible for ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Treatment of painful neuropathy


G Cruccu - Current opinion in neurology, 2007 - journals.lww.com
Recent findings: In addition to tricyclic antidepressants and gabapentin, the
reliability of which is established, some drugs have more recently been
demonstrated to be efficacious: major and minor opioids, pregabalin, and ...
Cited by 18 - Related articles - BL Direct - All 3 versions

[PDF] Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment …


A Veves, M Backonja, R Malik - Pain Medicine, 2008 - neurology.wisc.edu
Blackwell Publishing IncMalden, USAPMEPain Medicine1526-2375American Academy of
Pain Medicine? 200796660674 RESEARCH ARTICLESPainful Diabetic NeuropathyVeves et
al. ... Reprint requests to: Aristidis Veves, MD, Microcirculation ...
Cited by 17 - Related articles - View as HTML - All 6 versions

Clinical trial outcome in neuropathic pain: relationship to study characteristics


J Katz, NB Finnerup, RH Dworkin - Neurology, 2008 - AAN Enterprises
All rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X. since 1951,
it is now a weekly with 48 issues per year. Copyright © 2008 by AAN
Enterprises, Inc. ® is the official journal of the American Academy of ...
Cited by 15 - Related articles - All 4 versions

Painful diabetic neuropathy: treatment and future aspects


D Ziegler - Diabetes/Metabolism Reviews - interscience.wiley.com
Around one of three diabetic patients is affected by distal symmetric
polyneuropathy (DSP) which represents a major health problem, as it may present
with partly excruciating neuropathic pain and is responsible for ...
Cited by 9 - Related articles - BL Direct - All 3 versions

Management of painful diabetic neuropathy: what is new or in the pipeline for 2007?


D Ziegler - Current Diabetes Reports, 2007 - Springer
Approximately one of three diabetic patients is affected by distal symmetric
polyneuropathy, which represents a major health problem because it may present
with partly excruciating neuropathic pain and is responsible for ...
Cited by 2 - Related articles - BL Direct - All 2 versions

Duloxetine in the treatment of major psychiatric and neuropathic disorders


N Muller, R Schennach, M Riedel, HJ Moller - Expert Review of Neurotherapeutics, 2008 - ingentaconnect.com
Major depressive disorder (MDD) is one of the most disabling disorders.
Antidepressant pharmacotherapy is currently effective in approximately 70% of
all treated cases; the potential superiority of a dual mechanism of ...
Cited by 1 - Related articles - All 5 versions

[PDF] Current Treatments In the Management of Diabetic Peripheral Neuropathic


L KURITZKY, GP SAMRAJ - painmedicinenews.com
Unfortunately, DPN is widely underdiagnosed. A 2005 sur- vey by the American
Diabetes Association (ADA) (N=8,119) indicated that for most of the respondents
who experienced symptoms of DPN (75%), the condition had not been diag- ...
Related articles - All 2 versions

Population Pharmacokinetics of Orally Administered Duloxetine in Patients: Implications …

- adisonline.com [PDF] 
ED Lobo, T Quinlan, L OBrien, MP Knadler, … - Clinical Pharmacokinetics, 2009 - ingentaconnect.com
Abstract Objectives: The objectives of this analysis were to characterize the
pharmacokinetics of duloxetine at steady state in patients, estimate the
variability, identify significant covariates that may influence duloxetine ...
Related articles - All 3 versions

Predictors of Placebo Response in Pooled Lamotrigine Neuropathic Pain Clinical Trials


MC Irizarry, DJ Webb, Z Ali, BA Chizh, M Gold … - The Clinical journal of pain, 2009 - journals.lww.com
Michael C. Irizarry, MD, MPH,* David J. Webb, MSc,w Zahid Ali, PhD,z Boris A.
Chizh, MD, PhD,y Michael Gold, MS, MD,J Frances J. Kinrade, BSc,z Paul D.
Meisner, PharmD,J David Blum, MD,J# Marianne T. Silver, MS,J and John G. ...
Related articles - All 6 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google